tacrolimus ophthalmic
Off-label use
Description
Tacrolimus ophthalmic suspension is a calcineurin inhibitor used off-label for severe allergic eye diseases including vernal conjunctivitis. It provides potent anti-inflammatory effects by inhibiting T-cell activation and cytokine production. Studies have shown efficacy in steroid-resistant cases of vernal keratoconjunctivitis.
Indications & Therapeutic Use
vernal keratoconjunctivitis, atopic keratoconjunctivitis, severe allergic conjunctivitis
Linked Diseases:
Global Availability (5 countries)
Available Through
This drug is available for procurement through the following fulfilment partner.
Fulfilment Partner
tacrolimus ophthalmic
| Generic Name | tacrolimus ophthalmic |
| Active Ingredient | tacrolimus |
| Drug Class | vernal keratoconjunctivitis |
| Manufacturer | various |
| Dosage Forms | ophthalmic suspension 0.03%, 0.1% |
| Medical Code | S01XA20 |
| Orphan Status | No |
| Cold Chain | Not Required |
| Lead Time | 10 days |
| Reg. Status | Off-label use |
| Clinical Trial | NCT01751126 |
| Countries | 5 countries |
Authority Signals
Last Verified3/21/2026
Data ConfidenceHigh (AI + Pharmacist)
Source Citations6 Validated Nodes